Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
基本信息
- 批准号:10627751
- 负责人:
- 金额:$ 63.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:ADRBK1 geneArrestinsBar CodesBindingBiological AssayCXCRCXCR4 ReceptorsCell Surface ReceptorsCell SurvivalCell membraneCell surfaceCellsClinical TrialsComplexCouplesCritical PathwaysCryoelectron MicroscopyCytoplasmic TailDataDevelopmentDiseaseEndothelial CellsExtracellular SpaceG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGRK5 geneGTP-Binding ProteinsGoalsGrowthHandHeterotrimeric GTP-Binding ProteinsImmune responseInflammatory ResponseLeukocytesLigandsLymphomaLysosomesMalignant NeoplasmsMass Spectrum AnalysisMediatingMolecularMolecular ConformationNeoplasm MetastasisOutcomePathway interactionsPhenotypePhosphorylationPhysiologyPlayPrimary NeoplasmProcessProliferatingProtein IsoformsProteinsProto-Oncogene Proteins c-aktRegulationReportingResearchResolutionRoleSideSignal TransductionSiteSolid NeoplasmStromal Cell-Derived Factor 1StructureTherapeuticarrestin3biophysical techniquescancer cellcancer therapycell motilitychemokinechemokine receptordesensitizationextracellularinsightleukemiamigrationreceptorreceptor internalizationreconstructionrecruitresponsescaffoldstructural biologytumortumor growthuptake
项目摘要
PROJECT SUMMARY
Chemokines control the migration and localization of leukocytes and play fundamental roles in regulating
immune and inflammatory responses. One such chemokine, CXCL12, promotes multiple steps in the growth of
many primary tumors and progression to metastasis by binding to C-X-C chemokine receptor type 4 (CXCR4)
and atypical chemokine receptor 3 (ACKR3), which are upregulated in many cancers. Unlike most G protein-
coupled receptors (GPCRs), CXCL12-bound ACKR3 signals only via arrestins. In response to CXCL12,
ACKR3 is phosphorylated by intracellular GPCR kinases (GRKs) which subsequently recruit arrestins. The
arrestins serve as scaffolds that promotes growth pathways critical for cell survival, proliferation, and migration.
Arrestins also drive receptor internalization, during which CXCL12 is trafficked to lysosomes and degraded.
Afterwards, the empty receptor is recycled to the cell surface where it maintains a relatively stable
concentration. This process results in the "scavenging" or uptake of CXCL12 from the extracellular space and
is important for maintaining the responsiveness of CXCR4-expressing cells in the context of normal physiology
as well as tumor metastasis. In this proposal, the Tesmer and Handel labs, with deep expertise in GRKs and
chemokine receptor structure and function, respectively, join forces to better understand the molecular
mechanisms underlying ACKR3 phosphorylation by different GRKs, how arrestins interact with the resulting
phosphorylation “barcodes” installed in the C-terminus of the receptor, and what the cellular consequences
are. They have discovered that GRK2 and GRK5 phosphorylate activated ACKR3 at distinct regions of its
cytoplasmic tail. Moreover, phosphorylation enhances binding to both arrestin2 and 3. Arrestin2 recruitment
has not been reported before, and thus its functional significance remains to be elucidated. They have further
isolated complexes of ACKR3 with both arrestin as well as with GRK2–Gthat are of suitable quality for high
resolution cryo-electron microscopy (cryo-EM) reconstructions and have shown that G subunits alone can
form a strong interaction with ACKR3 of unknown function. In Aim1, cryo-EM structures of CXCL12-activated
ACKR3 will be determined in complex with various GRKs, with focus on GRK2, and with G. In Aim2, cryo-
EM will be used to examine arrestin complexes with phosphorylated ACKR3. In Aim 3, hypothesis driven cell-
based assays of ACKR3 function and unbiased mass spectrometry approaches will be used to systematically
investigate mechanisms by which these proteins control arrestin-mediated signaling and scavenging by
ACKR3 and determine if there is specific GRK and arrestin isoform control of ACKR3 function. The successful
conclusion of this proposal will result in the first structure of an atypical chemokine receptor in complex with its
intracellular signaling partners as well as unprecedented insights into the molecular mechanisms of a
therapeutically important receptor that may ultimately aid in the development of new cancer treatments.
项目摘要
趋化因子控制着白细胞的迁移和定位,在调节白细胞的增殖和分化中起着重要作用。
免疫和炎症反应。其中一种趋化因子CXCL 12促进了肿瘤细胞生长的多个步骤,
许多原发性肿瘤并通过与C-X-C趋化因子受体4型(CXCR 4)结合而进展为转移
和非典型趋化因子受体3(ACKR 3),其在许多癌症中上调。与大多数G蛋白不同-
偶联受体(GPCR),CXCL 12结合的ACKR 3仅通过抑制蛋白发出信号。针对CXCL 12,
ACKR 3被细胞内GPCR激酶(GRK)磷酸化,随后募集抑制蛋白。的
抑制蛋白用作促进对细胞存活、增殖和迁移至关重要的生长途径的支架。
抑制蛋白还驱动受体内化,在此期间CXCL 12被运输到溶酶体并降解。
然后,空受体再循环到细胞表面,在那里它保持相对稳定的细胞周期。
浓度.该过程导致CXCL 12从细胞外空间的“清除”或摄取,
在正常生理环境中,对于维持CXCR 4表达细胞的反应性是重要的
以及肿瘤转移。在这项提案中,Tesmer和Handel实验室在GRK方面拥有深厚的专业知识,
趋化因子受体的结构和功能,分别加入力量,以更好地了解分子
不同GRK的ACKR 3磷酸化的潜在机制,抑制蛋白如何与产生的
磷酸化“条形码”安装在受体的C末端,以及细胞的后果是什么?
是.他们发现GRK 2和GRK 5磷酸化激活ACKR 3的不同区域,
胞质尾此外,磷酸化增强与arrestin 2和3的结合。arrestin 2募集
以前没有报道,因此其功能意义仍有待阐明。它们进一步
分离的ACKR 3与抑制蛋白以及与GRK 2-G抑制蛋白的复合物,其具有适合高质量的
分辨率冷冻电子显微镜(cryo-EM)重建,并已表明G蛋白亚基单独可以
与未知功能的ACKR 3形成强相互作用。在Aim 1中,CXCL 12激活的细胞的冷冻-EM结构
ACKR 3将与各种GRK一起确定,重点是GRK 2和G RK。在目标2中,低温-
EM将用于检查具有磷酸化ACKR 3的抑制蛋白复合物。在目标3中,假设驱动的细胞-
基于ACKR 3功能的测定和无偏质谱法将用于系统地
研究这些蛋白质控制arrestin介导的信号传导和清除的机制,
并确定是否有特定的GRK和抑制蛋白亚型控制ACKR 3功能。成功
这一建议的结论将导致非典型趋化因子受体的第一个结构,
细胞内信号的合作伙伴,以及前所未有的见解的分子机制,
这些受体可能最终有助于开发新的癌症治疗方法。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
G protein-coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias.
- DOI:10.1016/j.jbc.2022.102279
- 发表时间:2022-09
- 期刊:
- 影响因子:4.8
- 作者:Chen, Qiuyan;Tesmer, John J. G.
- 通讯作者:Tesmer, John J. G.
The Open Question of How GPCRs Interact with GPCR Kinases (GRKs).
- DOI:10.3390/biom11030447
- 发表时间:2021-03-17
- 期刊:
- 影响因子:5.5
- 作者:Cato MC;Yen YC;Francis CJ;Elkins KE;Shareef A;Sterne-Marr R;Tesmer JJG
- 通讯作者:Tesmer JJG
Generation of Highly Selective, Potent, and Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors.
- DOI:10.1021/acs.jmedchem.0c01522
- 发表时间:2021-01-14
- 期刊:
- 影响因子:7.3
- 作者:Rowlands RA;Chen Q;Bouley RA;Avramova LV;Tesmer JJG;White AD
- 通讯作者:White AD
Structures of rhodopsin in complex with G-protein-coupled receptor kinase 1.
与G蛋白偶联受体激酶1的复合物中的视紫红质结构。
- DOI:10.1038/s41586-021-03721-x
- 发表时间:2021-07
- 期刊:
- 影响因子:64.8
- 作者:Chen Q;Plasencia M;Li Z;Mukherjee S;Patra D;Chen CL;Klose T;Yao XQ;Kossiakoff AA;Chang L;Andrews PC;Tesmer JJG
- 通讯作者:Tesmer JJG
Residue-wise local quality estimation for protein models from cryo-EM maps.
- DOI:10.1038/s41592-022-01574-4
- 发表时间:2022-09
- 期刊:
- 影响因子:48
- 作者:Terashi, Genki;Wang, Xiao;Subramaniya, Sai Raghavendra Maddhuri Venkata;Tesmer, John J. G.;Kihara, Daisuke
- 通讯作者:Kihara, Daisuke
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracy M Handel其他文献
Tracy M Handel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracy M Handel', 18)}}的其他基金
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
这是一场拉锯战:CXCR4 和 ACKR3 对淋巴细胞趋化剂 CXCL12 反应的结构、后果和抑制
- 批准号:
10393668 - 财政年份:2021
- 资助金额:
$ 63.17万 - 项目类别:
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
这是一场拉锯战:CXCR4 和 ACKR3 对淋巴细胞趋化剂 CXCL12 反应的结构、后果和抑制
- 批准号:
10597645 - 财政年份:2021
- 资助金额:
$ 63.17万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10559615 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10727691 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10488001 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10397636 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
9917599 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10162570 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10360504 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Insights into Activation Mechanisms of G Protein-Coupled and Atypical β-Arrestin-Coupled Chemokine Receptors
深入了解 G 蛋白偶联和非典型 β-抑制蛋白偶联趋化因子受体的激活机制
- 批准号:
9899267 - 财政年份:2019
- 资助金额:
$ 63.17万 - 项目类别:
相似国自然基金
AT1R-G蛋白/β-arrestins通路偏好性激活在急性肾损伤中的作用及其机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
催产素受体Gαq与β-arrestins偏爱型信号通路在产后抑郁症中的作用
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-arrestins在DC细胞迁移及自身免疫疾病中的作用及机制研究
- 批准号:31871404
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
β-arrestins调节小胶质细胞M1/M2表型转化及其在阿尔兹海默病进程中的作用
- 批准号:81703488
- 批准年份:2017
- 资助金额:20.1 万元
- 项目类别:青年科学基金项目
β-arrestins保护心肌梗死的作用和机制研究
- 批准号:81670260
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
beta-arrestins在自感光神经节细胞光信号转导中的作用和机制研究
- 批准号:31601134
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
β-arrestins通过ER stress/Puma调控门脉高压性胃病的机制
- 批准号:81370511
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
支气管上皮细胞恶性转化中β-arrestins的作用及其机制研究
- 批准号:81301728
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
β-arrestins介导甘丙肽2型受体信号转导的作用机理及其可能的抗抑郁机制
- 批准号:31171032
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
β-arrestins在缺血再灌注性肝损伤及其修复中的作用和机制
- 批准号:81170422
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 63.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Collaborative Research: Alpha-arrestins' impact on cellular physiology
合作研究:α-抑制蛋白对细胞生理学的影响
- 批准号:
2321625 - 财政年份:2023
- 资助金额:
$ 63.17万 - 项目类别:
Standard Grant
Collaborative Research: Alpha-arrestins' impact on cellular physiology
合作研究:α-抑制蛋白对细胞生理学的影响
- 批准号:
2321624 - 财政年份:2023
- 资助金额:
$ 63.17万 - 项目类别:
Standard Grant
Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
- 批准号:
10704588 - 财政年份:2022
- 资助金额:
$ 63.17万 - 项目类别:
Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
- 批准号:
10536255 - 财政年份:2022
- 资助金额:
$ 63.17万 - 项目类别:
FASEB SRC: The G Protein-coupled Receptor Kinases and Arrestins Conference: Key Modulators of Signal Transduction
FASEB SRC:G 蛋白偶联受体激酶和抑制蛋白会议:信号转导的关键调节剂
- 批准号:
10464336 - 财政年份:2022
- 资助金额:
$ 63.17万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10397636 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10162570 - 财政年份:2020
- 资助金额:
$ 63.17万 - 项目类别: